Division of Reconstructive Plastic Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden; Department of Surgery, Södersjukhuset, Stockholm, Sweden.
J Plast Reconstr Aesthet Surg. 2020 Aug;73(8):1540-1546. doi: 10.1016/j.bjps.2020.02.038. Epub 2020 Mar 17.
Completion lymph node dissection (CLND) for malignant melanoma is performed for regional cancer control and is associated with a high complication rate. It is unknown whether post-operative complications influence cancer recurrence or survival. Our aim was to evaluate the risk factors for short- and long-term complications after CLND, and to determine whether complications affect recurrence or survival.
We performed a retrospective cohort study including all melanoma patients who underwent CLND in the Stockholm region during 2005-2014. Patient and cancer characteristics were collected from medical records, as were clinical outcomes. Assessment was performed by multivariate logistic regression.
Among 144 patients, the risk of any post-operative one year complication was 68.8%. Lymphedema (41.0%), infection (37.5 %), and seroma (31.3 %) were the most common complications. Diabetes and inguinal CLND were associated with nine- and ten-fold increased risks of post-operative complications (p<0.05), respectively. Complications were linked to an increased risk of recurrent cancer (p<0.05), median follow-up time of 49 months, but did not appear to affect five-year survival.
Post-operative complications are common in melanoma patients undergoing CLND. Strong risk factors for complications are diabetes and inguinal CLND. Post-operative complications appear to be associated with increased risks of recurrent cancer, but the mechanism is unknown.
完成淋巴结清扫术(CLND)用于恶性黑色素瘤的区域癌症控制,与高并发症发生率相关。术后并发症是否影响癌症复发或生存尚不清楚。我们的目的是评估 CLND 后短期和长期并发症的危险因素,并确定并发症是否影响复发或生存。
我们进行了一项回顾性队列研究,纳入了 2005 年至 2014 年期间在斯德哥尔摩地区接受 CLND 的所有黑色素瘤患者。从病历中收集患者和癌症特征以及临床结果。通过多变量逻辑回归进行评估。
在 144 例患者中,任何术后一年并发症的风险为 68.8%。淋巴水肿(41.0%)、感染(37.5%)和血清肿(31.3%)是最常见的并发症。糖尿病和腹股沟 CLND 与术后并发症的风险增加 9 倍和 10 倍相关(p<0.05)。并发症与癌症复发风险增加相关(p<0.05),中位随访时间为 49 个月,但似乎不影响五年生存率。
接受 CLND 的黑色素瘤患者术后并发症常见。并发症的强危险因素是糖尿病和腹股沟 CLND。术后并发症似乎与癌症复发风险增加相关,但机制尚不清楚。